Eva Heger
- Infectious Diseases top 5%
- Epidemiology
- Hepatology top 10%
- Molecular Biology
- Virology top 5%
- Co-authors
- Rolf KaiserElena KnopsVeronica Di CristanzianoFlorian KleinSaleta SierraThomas LengauerClara LehmannPrabhav Kalaghatgi
- Topics
- HIV/AIDS drug development and treatment (18 papers)HIV Research and Treatment (16 papers)SARS-CoV-2 and COVID-19 Research (15 papers)
In The Last Decade
Eva Heger
49 papers receiving 600 citations
Peers
Comparison fields: 5 of 77
- Infectious Diseases 394
- Epidemiology 181
- Hepatology 100
- Molecular Biology 98
- Virology 97
Countries citing papers authored by Eva Heger
This map shows the geographic impact of Eva Heger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Heger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Heger more than expected).
Fields of papers citing papers by Eva Heger
This network shows the impact of papers produced by Eva Heger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Heger. The network helps show where Eva Heger may publish in the future.
Co-authorship network of co-authors of Eva Heger
This figure shows the co-authorship network connecting the top 25 collaborators of Eva Heger. A scholar is included among the top collaborators of Eva Heger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Heger. Eva Heger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | 13 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 12 | |
| 11 | 4 | |
| 12 | 9 | |
| 13 | 8 | |
| 14 | 1 | |
| 15 | 6 | |
| 16 | 14 | |
| 17 | 51 | |
| 18 | 28 | |
| 19 | 8 | |
| 20 | 14 |
About Eva Heger
Eva Heger is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 53 papers that have together received 612 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (16 papers) and SARS-CoV-2 and COVID-19 Research (15 papers). The work is most often cited by research in Infectious Diseases (394 citations), Virology (97 citations) and Hepatology (100 citations). Eva Heger has collaborated with scholars based in Germany, Italy and Slovakia. Frequent co-authors include Rolf Kaiser, Elena Knops, Veronica Di Cristanziano, Florian Klein, Saleta Sierra, Thomas Lengauer, Clara Lehmann, Prabhav Kalaghatgi, Martin Obermeier and Udo Holtick. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.